Yahoo · Nov 1, 2026
Cencora (COR) Stock Still Looks Undervalued After Its 173% Run
Cencora has put up a powerful long term share price performance, yet the current US$330.84 price invites a sharper question. Are the cash flows behind the business strong enough, and predictable enough, to make that level look well supported? Over the past 5 years the stock is up 172.6%, which puts a lot of weight on whether the underlying cash generation matches the market's enthusiasm. The planned US$2.4b purchase of American Oncology Network can reshape how quickly Cencora converts its...

